Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

University of Pittsburgh study finds an osteoporosis drug prevents bone loss side effects of breast cancer medication:

Posted Oct 12 2011 10:23pm
University of Pittsburgh study finds an osteoporosis drug prevents bone loss side effects of breast cancer medication: NCI Cancer Center News

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.

Click here to read full press release from University of Pittsburgh .

###

NCI comprehensive cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Post a comment
Write a comment:

Related Searches